Steve Thorne

Company: KaliVir Immnuotherapeutics

Job title: CSO

Seminars:

The Design of Oncolytic Viral Therapies for Intravenous Delivery 11:45 am

• Next generation OV therapies will ideally be delivered intravenously • Modifications of the viral backbone can increase systemic delivery • Addition of therapeutic transgene combinations can create potent systemic therapiesRead more

day: Day One